Merz Aesthetics Announces Expanded U.S. Availability of the Cellfina™ System

, a division of Merz North America (US affiliate of the
global Merz Pharma Group), announced today that they have begun
commercial shipment of the Cellfina™
to aesthetic practices in the U.S. market. Cellfina™ is the
only FDA-cleared minimally invasive procedure clinically proven to
improve the appearance of cellulite in the buttocks and thighs of adult
females, for results that last at least two years, the longest duration
cleared by the FDA.

“This month’s product shipments represent a key milestone as we begin
the full commercial launch of the Cellfina™ System in the U.S. market,”
said Patrick Urban, Vice President and U.S. Head of the Merz Aesthetics
Device business. “Interest in Cellfina™ has continued to grow over the
past months, as evidenced by the ongoing national media coverage of this
unique cellulite treatment, including mentions on The Doctors, Good
Morning America and the Dr. Oz Show. With approximately 85% of U.S.
women reporting concerns with cellulite1, we look forward to
bringing this effective treatment option to more patients in the months
to come.”

The Cellfina™ System combines highly advanced, proprietary technology
with a well-established procedure called subcision, to treat the primary
structural cause of dimpled cellulite. In clinical trials, patient
satisfaction with the results of Cellfina™ treatment improved from 94%
at one year to 96% patient satisfaction at the two year mark. The most
common side effects reported were soreness, tenderness, and bruising.

“For adult women who want to improve the appearance of cellulite on the
thighs and buttocks, I have found Cellfina™ to be a safe and effective
treatment option that requires only one session for lasting results,”
said Dr.
Joel L. Cohen
. “In my own practice, treatment with Cellfina™ has
continued to yield very high patient satisfaction rates and lasting
results.” Joel L. Cohen, MD has been performing Cellfina™ treatments
since November 2014; he is a board-certified dermatologist in private
practice in Denver, Colorado and is the Director of AboutSkin
Dermatology and DermSurgery in Englewood and Lone Tree, Colorado. He
also serves on the volunteer faculty of the University of Colorado as an
Associate Clinical Professor, and as an assistant clinical professor at
the University of California at Irvine.

Cellfina™ is currently available in 28 aesthetic practices in most major
markets in the U.S., with more locations being added in the coming
months. To find a full list of current and “Coming Soon” providers,
please visit

About Cellfina™

The Cellfina™ System is intended for long-term improvement in the
appearance of cellulite in the buttocks and thigh areas of adult
females. Safety and effectiveness in other anatomical areas have not
been established. The most common side effects reported were soreness,
tenderness, and bruising. The Cellfina™ System is only available through
a licensed physician. For full product and safety information, visit

About Merz Aesthetics

Merz Aesthetics is a division of Merz North America, a specialty
healthcare company that develops and commercializes treatment solutions
in aesthetics, dermatology and neurosciences in the U.S. and Canada. As
part of the Merz Pharma Group of companies, our ambition is to become
the most admired, trusted and innovative aesthetics and neurotoxin
company. By developing products that improve patients’ health and help
them to live better, feel better and look better, Merz will continue to
make significant contributions to the well-being of individuals around
the world. Merz Aesthetics provides a range of treatment options,
including devices, injectables and skincare, that enable physicians to
use Merz technologies to treat a variety of patients and concerns. For
more information about Merz Aesthetics and their U.S. product portfolio,
please visit

1 Cellulite Meltdown. Harvard Women’s Health Watch.


Merz North America
Mariana Smith Bourland, 336-339-0172